Dopamine Receptor D1 Antibody (NB110-60017B)

Dopamine Receptor D1 Antibody (SG2-D1a) [Biotin]

100% Guarantee This product is fully covered under the Novus guarantee+ Policy. Click here for details.

Distributor Data...

Loading Ajax
Loading...
Loading...Unit Size: 0.1 ml
 
Bulk Request
Dopamine Receptor D1 Antibody (SG2-D1a) [Biotin] Summary:
Species:Bv(-), Ca(-), Hu(-), Mu, Po(-), Rb(-), Rt, Sh(-)
Applications:ICC, IF, WB
Clonality:Monoclonal
Gene:DRD1
Purity:Protein A purified
Host:Mouse
Specificity:This reacts with Dopamine Receptor D1A. There is no cross- reactivity with D1B (D5) receptor.
 
Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur.
View Additional Dopamine Receptor D1 Products
Dopamine Receptor D1 Antibody (SG2-D1a) [Biotin] Details:
Conjugate:Biotin
Clone:SG2-D1a
Isotype:IgG2b Kappa
Immunogen:Recombinant rat D1 (D1a) dopamine receptor protein near the C-terminus. [Swiss-Prot# P18901]
Localization:Cell membrane; Multi-pass membrane protein. Endoplasmic reticulum membrane; Multi-pass membrane protein. Note: Transport from the endoplasmic reticulum to the cell surface is regulated by interaction with DNAJC14.
Epitope:This antibody has not been epitope mapped.
Species Reactivity:

This antibody reacts with mouse and rat protein. It does not react with human, dog, pig, sheep, rabbit, or cow proteins. Other species have not been tested.

Applications:
Uses:This antibody is useful for Western Blot analysis, where multiple bands are seen around 45 and 100 kDa (dimer) in sf9 cell lysates overexpressing D1a and a single band at 90 kDa in striatal tissue lysate. Do NOT boil samples. Immunocytochemistry and immunofluorescence have been useful using other productions of this antibody.
Dilutions:immunofluorescence , Western Blot 2 ug/ml, Immunocytochemistry
Unit Size:0.1 ml
Concentration:1.4 mg/ml
Positive Controls:1 Positive Controls
Conjugated Antibodies:4 Conjugated Antibodies
Packaging:
Storage:Store at 4 °C. Do not freeze.
Buffer:PBS
Preservative:No Preservative
Limitations:This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months.
Gene Symbol: DRD1
Entrez1812 (Human)
 
Background:

The members of the G protein-coupled receptor family are distinguished by their slow transmitting response to ligand binding. These seven transmembrane proteins include the adrenergic, serotonin, and dopamine receptors. The effect of the signaling molecule can be excitatory or inhibitory depending on the type of receptor to which it binds. Beta-adrenergic receptor bound to adrenaline activates adenylyl cyclase, while alpha 2-adrenergic receptor bound to adrenaline inhibits adenylyl cyclase. The dopamine receptors are divided into two classes; D1 and D2, which differ in their functional characteristics. D1 receptors stimulate adenylyl cyclase, while D2 receptors inhibit adenylyl cyclase activity. Five different subtypes of dopamine receptor have been described to date. D1DR and D5DR belong to the D1 subclass, while D2DR, D3DR and D4DR belong to the D2 subclass of dopamine receptors.

Jump to: Ask a Question

Working with Dopamine Receptor D1

Dopamine Receptor D1 Antibody (SG2-D1a) [Biotin] Images (0)
Reviews (0)  Have you used this product? Review this product to earn Novus Rewards.

Ask a Scientist

Can't find an answer to your question about Dopamine Receptor D1? Ask us by using live chat or by submitting your questions below:

 
Jump to: Conjugated Antibodies, Positive Controls, Lysates, Peptides and Proteins, Primary Antibodies, RNAi, Secondary Antibodies

Related Products

Conjugated Antibodies
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
Dopamine Receptor D1 Antibody (SG2-D1a) [DyLight 488]NB110-60017GBv(-), Ca(-), Hu(-), Mu, Po(-), Rb(-), Rt, Sh(-)ICC, IF, WB

Dopamine Receptor D1 Antibody (SG2-D1a) [DyLight 550]NB110-60017RBv(-), Ca(-), Hu(-), Mu, Po(-), Rb(-), Rt, Sh(-)ICC, IF, WB

Dopamine Receptor D1 Antibody (SG2-D1a) [DyLight 650]NB110-60017CBv(-), Ca(-), Hu(-), Mu, Po(-), Rb(-), Rt, Sh(-)ICC, IF, WB

Dopamine Receptor D1 Antibody (SG2-D1a) [HRP]NB110-60017HBv(-), Ca(-), Hu(-), Mu, Po(-), Rb(-), Rt, Sh(-)ICC, IF, WB

Positive Controls
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
Other Positive Controls
  • Sf9 cell and striatal tissue lysates.
Lysates (1)
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
Dopamine Receptor D1 LysateNBL1-10015WB(1)

Peptides and Proteins
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
Dopamine Receptor D1 ProteinH00001812-G01HuFunc

Primary Antibodies (10)
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
Dopamine Receptor D1 Antibody (SG2-D1a)NB110-60017Bv(-), Ca(-), Hu(-), Mu, Po(-), Rb(-), Rt, Sh(-)ICC, IF, IHC, WB(1)(2)

Dopamine Receptor D1 Antibody (EP1560Y)NB100-79930Hu, Mu, RtFACS, WB(1)(4)

Dopamine Receptor D1 AntibodyNBP1-87577HuIF, IHC-P, WB(1)

Dopamine Receptor D1 AntibodyNLS44HuICC, IHC-P(2)

Dopamine Receptor D1 AntibodyNBP1-04727HuELISA(2)

... and 5 more. See All »
RNAi (1)
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
Dopamine Receptor D1 RNAiH00001812-R02Hu(1)(4)

Secondary Antibodies
NameCatalog#ReactivityApplicationsImagesPublicationsReviews
Mouse IgG Antibody [Biotin]NB720-BMuELISA, IHC-P, WB

Mouse IgG Antibody [HRP]NB720-HMuELISA, ICC, IHC-P, WB

Mouse IgG Antibody [Alkaline Phosphatase]NB720-APMuELISA, ICC, IHC-P, WB

Mouse IgG Antibody [FITC]NB720-FMuICC, IHC-P(2)

Mouse IgG AntibodyNB120-7056Bv(-), Ch(-), Eq(-), Gp(-), Gt(-), Ha(-), Hu(-), Mu, Rb(-), Rt(-), Sh(-)ELISA, IHC-P, IP, WB

See All »

Jump to: Novus Explorer, Research Areas

Dopamine Receptor D1 in Context


Research Areas related to Dopamine Receptor D1 (3):
Novus Explorer for Dopamine Receptor D1 gene

Try our bioinformatic tool that shows the relationships between DRD1 and other genes, diseases, pathways and post-translational modifications.